Cite
MLA Citation
Brett Doble et al.. “Cost-effectiveness of precision medicine in the fourth-line treatment of metastatic lung adenocarcinoma: An early decision analytic model of multiplex targeted sequencing.” Lung cancer, vol. 107, 2017, pp. 22–35. http://access.bl.uk/ark:/81055/vdc_100045296670.0x000010